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Abstract
Aims: Optimal ostial seating and adequate back-up of guide catheters are required for challenging percutane-
ous coronary interventions (PCI). The GuideLiner™ (GL) (Vascular Solutions Inc., Minneapolis, MN, USA) 
is a guide catheter extension system that provides active back-up support by deep coronary intubation. We 
aimed to assess feasibility and safety of GL-use in routine clinical practice.
Methods and results: We prospectively recorded patient and procedural details, technical success, and in-
hospital outcome of 65 consecutive patients undergoing “5-in-6” Fr GL-facilitated PCI of 70 target vessels. The 
GL was mainly used for PCI of complex coronary lesions: 97% (68/70) had American Heart Association/Ameri-
can College of Cardiology (AHA/ACC) lesion types B2/C; 53% (37/70) were distally located; and 23% (17/70) 
were heavily calcified. Indications were to increase back-up of the guide and facilitate stent delivery (59%; 
41/70), achievement of coaxial alignment of the guide catheter (29%; 20/70), and selective contrast injections 
(13%; 9/70). Device success rate was 93% (65/70). There were no major complications and two minor compli-
cations managed without clinical sequelae: one air embolism and one stent dislodgement.
Conclusions: GL-use resulted in increased back-up and guide catheter alignment for stent delivery in unfa-
vourable tortuous coronary anatomies and complex, heavily calcified, and often distally located lesions, 
which otherwise may have been considered unsuitable for PCI. Procedural success rate was high and there 
were no major complications.
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Abbreviations
ACS acute coronary syndrome
CK creatine kinase
CTO chronic total occlusion
DES drug-eluting stents
GEA gastroepiploic artery
GL GuideLiner
LAD left anterior descending coronary artery
LCX left circumflex coronary artery
LM left main
NSTEMI non-ST-elevation myocardial infarction
PCI percutaneous coronary intervention
STEMI ST-elevation myocardial infarction
RCA right coronary artery
UAP unstable angina pectoris
Introduction
Despite the advancements made in percutaneous coronary interven-
tions, the interventional cardiologist nowadays has to deal with an 
increasing complexity of procedures. A good back-up of the guide 
catheter is essential to advance guidewires and balloons, and to 
deliver stents. Support of the guide can be increased by use of extra 
back-up guides and larger guide dimensions. In addition, the stabil-
ity of the guide can be improved by advancing a buddy wire, and 
use of stiffer guidewires or anchoring balloons1,2. Another way to 
increase back-up support is deep intubation of the guide3,4. There is, 
however, a considerable risk of dissecting the vessel. Introduction 
of guide catheter extension systems, in which a long guide catheter 
with a flexible tip is advanced through the mother guide, has further 
refined this concept5-7. Besides the improvement in back-up sup-
port, the use of guide catheter extensions provides selective visuali-
sation of the target vessel, improves the stability of the guide and 
allows coaxial alignment of the guide.
There are three systems available: the Heartrail® II catheter (Terumo 
Corp., Tokyo, Japan), the Proxis™ device (St Jude Medical, St Paul, 
MN, USA) and the GuideLiner™ catheter (Vascular Solutions Inc., 
Minneapolis, MN, USA). The Heartrail® II catheter and Proxis™ device 
are 120 cm catheters that are introduced into the mother guide by remov-
ing the Y-connector6-9. The GuideLiner (GL) catheter (Figure 1) is 
a novel rapid exchange guide catheter extension system that provides 
active guide support by its 20 cm-long flexible tubular end, which can be 
deeply advanced into target vessels10-18. Its handling is particularly easy, 
as it is does not require disconnection of the haemostatic valve at the 
proximal end of the guide catheter and is compatible with standard 
180 cm-long guidewires. Its soft distal tip promises a low risk of dissect-
ing vessels compared to the deep-seating of regular guide catheters.
So far, only a limited number of reports and case series have been 
published on the GL guide catheter extension10-18. Mamas et al 
reported a case series of 13 complex coronary interventions, per-
formed via the radial artery with the “5-in-6” Fr GL system10. 
Although their success rate was high, the main limitation encoun-
tered was stent damage upon advancement of the stent across the 
metallic collar of the GL (two out of 32 stents)10. Recently, Luna et 
al published their experience with the GL catheter in a series of 
21 patients15. In their study, a transfemoral approach and 7 Fr guide 
catheters were used in the majority of the cases with a procedural 
success rate of 90%. Pressure dampening was seen in 57% of their 
patients, contributing to three out of four unsuccessful cases. There 
was one major complication in the series reported by Luna et al, 
which was a flow-limiting dissection in the proximal left anterior 
descending coronary artery (LAD) but they noted no case of stent 
damage15. The purpose of the present Twente GuideLiner registry 
was to assess feasibility and safety of use of the “5-in-6” Fr GL 
guide catheter extension system during routine, clinical PCI proce-
dures as performed at Thoraxcentrum Twente, a high-volume PCI 
centre located in Enschede, The Netherlands.
Figure 1. Schematic presentation of the GuideLiner catheter.
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Methods
STUDY POPULATION
Between November 2010 and July 2011, we prospectively col-
lected data from a consecutive series of 65 patients, in whom the 
GL was applied to facilitate routine PCI. The patients had a back-
ground of stable or unstable angina pectoris, or presented with an 
acute myocardial infarction.
INTERVENTIONAL PROCEDURES
A team of five interventional cardiologists performed the PCI proce-
dures; each of them had performed PCI for more than five years (250-
500 PCI procedures per operator annually; total PCI experience of 
4,000 or more per operator). PCI procedures were performed accord-
ing to standard clinical protocols via the femoral or radial routes, using 
6 Fr guide catheters as a standard. All patients received a bolus of 
unfractionated heparin (5,000 IE or 70-100 IE/kg). Prior to PCI, all 
patients received adequate loading doses of acetylsalicylic acid 
(300 mg) and clopidogrel (300-600 mg), if not pretreated. During the 
procedure, an intracoronary bolus of nitrates was administered. The 
choice of interventional approaches, devices, and techniques was left at 
the operators’ discretion, considering current clinical protocols and 
guidelines. Following PCI, clopidogrel was prescribed for one year 
(75 mg once daily [o.d.] in addition to life-long treatment with acetyl-
salicylic acid [at least 100 mg o.d.]).
THE GUIDELINER CATHETER AND ITS USE
The GL (Vascular Solutions, Minneapolis, MN, USA) consists of 
a flexible, 20 cm, straight, flexible, soft-tipped extension tube that is 
connected via a metal collar to a thin 115 cm-long stainless steel shaft 
(Figure 1A and Figure 1B). The extension tube has a silicon coating for 
lubricity. The procedure starts by positioning the mother guide and 
advancing the guidewire across the target lesion. Then the GL is 
advanced over the guidewire through the haemostatic valve of the 
Y-adapter (handling comparable to regular balloons) to intubate the 
target coronary artery or bypass graft (Figure 1C). The GL reduces the 
inner diameter of the mother guide by approximately 1 Fr, but it does 
not lengthen the guide outside the patient. When the GL is in place, 
balloons and stents can be delivered over the same initial guidewire. 
The GL is available in sizes of 6 Fr, 7 Fr, and 8 Fr. In this study, only 
6 Fr GL were used (also called the “5-in-6” Fr system), which has an 
internal diameter of 0.056” (1.422 mm). Notably, the use in vessels 
<2.5 mm is discouraged by the manufacturer. Bifurcation lesions in 
our study were treated as follows: two wires were advanced through 
the guide. Then, the GL was advanced over both wires simultane-
ously. Provisional stenting was the strategy of choice. In cases where 
a kissing balloon technique was demanded, a wire exchange was per-
formed followed by balloon dilation of the side branch through the 
stent struts. Before the final kissing balloon inflation could be per-
formed, the GL had to be removed.
STUDY PARAMETERS AND DATA ACQUISITION
To assess the usefulness (feasibility and safety) of the GL in clinical 
practice, we prospectively recorded various procedural data and clinical 
Table 1. Demographic characteristics of study population.
Age (years) 67±13
Male gender 74% (48/65)
Hypertension 57% (37/61)
Hypercholesterolaemia 54% (35/61)
Diabetes 25% (16/65)
Current smoking 22% (14/61)
Family history of CAD 28% (18/61)
Prior myocardial infarction 32% (21/65)
Prior PCI 26% (17/65)
Prior CABG 26% (17/65)
Indication for PCI
ST-elevation MI 12% (8/65)
Non-ST-elevation MI 20% (13/65)
Unstable angina 6% (4/65)
Stable angina 62% (40/65)
CAD: coronary artery disease; PCI: percutaneous coronary intervention; 
CABG: coronary artery bypass graft; MI: myocardial infarction
details on the in-hospital outcome of a consecutive series of 65 
patients, who underwent PCI with the use of the GL. Patient demo-
graphics, indication for GL use, angiographic and procedural details 
including technical success, and all complications were recorded. 
Quantitative coronary angiography (QCA) was used to determine the 
intubation depth of the GL catheter. Procedural success was defined as 
the achievement of <20% diameter stenosis with TIMI 3 flow in the 
target vessel. Routine peri-interventional assessment of cardiac bio-
markers was performed to screen for PCI-induced myocardial necro-
sis up to 24 hours after PCI or until the highest value of creatine kinase 
(CK) was measured. Peri-PCI myocardial infarction was defined as 
two times the upper reference limit of CK, confirmed by significant 
elevation of other specific biomarkers (MB-fraction of CK or troponin).
STATISTICAL ANALYSIS
Values are expressed as mean±SD. Comparison of continuous varia-
bles was performed with the Student’s t-test. Categorical variables 
are presented as numbers or percentages and were tested with the 
chi-square test or Fisher's exact test. A p-value <0.05 was considered 
statistically significant. Statistical analysis was performed with SPSS 
version 15.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results
PATIENT POPULATION AND LESION CHARACTERISTICS
The demographic characteristics of the study population are pre-
sented in Table 1. The majority of patients were male (74%), and the 
mean age was 67±13 years. Target lesions were relatively complex as 
is shown in Table 2. Most lesions (97%) had American Heart Asso-
ciation/American College of Cardiology (AHA/ACC) lesion types 
B2 or C, with more than half of them being located in distal vessel 
segments. A total of 90% of lesions was classified as being calcified: 
67% mild to moderately and 23% heavily calcified. Mean lesion 
length was 38±26 mm, which is indicative of long lesions.
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INDICATION FOR GL USE AND PROCEDURAL DETAILS
All procedures were carried out with the “5-in-6” Fr GL device. As shown 
in Figure 3, the primary indications for GL use were to increase back-up 
of the guide catheter, in general to facilitate stent delivery (59%), and to 
improve alignment of the guide catheter (29%) (Table 3). In a few patients 
(13%), the GL was used for selective contrast injection, predominantly 
because of dominant left coronary artery (LCA) and/or renal impairment. 
There were differences between the application in right coronary artery 
Table 3. Procedural details, success, failures, and complications.
Procedural details
Radial access 22/65 (34%)
Multivessel procedure 19/65 (29%)
Procedural time (min) 79±43
Volume of contrast (ml) 220±118
Total length of stents implanted (mm) 41±29
Number of stents implanted 1.8±1.2
Depth of GuideLiner intubation (mm) 33±21
Primary indication for GuideLiner use
Improvement of back-up and facilitated 
stent delivery
41/70 (59%)
More selective contrast injection 9/70 (13%)
Improvement of alignment of the guide 20/70 (29%)
Success, failures, and complications
Device success 65/70 (93%)
Procedural success 64/70 (91%)
Major complications 0/70
Minor complications 2/70 (3%)
Air embolism 1/70 (1%)
Stent dislodgement 1/70 (1%)
Table 2. Target vessels and lesion characteristics.
Target vessels
Left anterior descending artery 17/70 (24%)
Left circumflex artery 20/70 (29%)
Right coronary artery 23/70 (33%)
Vein graft 10/70 (14%)
Target lesions
Type B2/C lesion 68/70 (97%)
Distal location 37/70 (53%)
Severe calcification 16/70 (23%)
Chronic total occlusion 12/70 (17%)
Reference vessel diameter (mm) 3.0±0.5
Diameter stenosis (%) 89±13
Lesion length (mm) 38±26
Figure 2. Angiography of a chronically occluded RCA in a 55-year-old female patient (A). Wire crossing was achieved using a pilot 50 wire. 
After subsequent passage and dilation with low profile balloons, the flow is partially restored and a long dissection can be noted that extends 
into the postero-lateral branch (B). Passage of a stent was unsuccessful due to marked resistance in the distal segment of the vessel. With the 
help of an anchoring balloon, the GuideLiner catheter was deeply intubated over the guidewire (C). Then, several drug-eluting stents were 
successfully delivered and postdilated, with a good final angiographic result (D).
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Figure 3. Angiographic overview of the device failures: Case #1) The first case was a 79-year-old male patient with an acute inferior MI. The 
target lesion was located in a diffusely diseased, heavily calcified RCA. The GL could not be advanced through the guide catheter because of 
severe iliac tortuosity (A), but procedural success was accomplished by use of a 3DRC guide catheter, two guidewires, and a distal anchoring 
balloon. Case #2) The second case was a long and calcified proximal LCX lesion, located behind a sharp angle between the LM and LCX that 
prevented GL intubation (B). Case #3) The third case was a 56-year-old subject who underwent an elective PCI of a diffusely diseased RCA. 
The GL catheter could not be intubated in the vessel due to a proximal lesion (C). The procedure was finished successfully with an AL1 guide. 
Case #4) In the fourth patient, the target lesion was a heavily calcified long mid RCA lesion (D). The proximal RCA segment was diffusely 
diseased, which prevented deep GL intubation (a depth of only 5 mm) and resulted in insufficient support; however, this problem was solved by 
rotablation of the ostium. Case #5) The fifth case was a vital 87-year-old female with stable angina due to a severely calcified proximal lesion 
in an 18-year-old saphenous vein graft. An AL2 guide catheter was positioned in the ostium and a flexible guidewire with hydrophilic coating 
was advanced across the lesion. Use of the GL was attempted to increase back-up support but the GL could not be advanced into the ostium 
(E), and the PCI procedure was terminated as a second guidewire could not pass the ostium either. We discussed the patient with our thoracic 
surgeons, who then performed an elective repeat bypass surgery with an uneventful clinical course.
(RCA) and LCA interventions. In the LCA, the GL catheter was used 
regularly to improve the alignment of the guide or enhance selective con-
trast injections, whereas its use in RCA interventions was mainly to 
increase catheter back-up (p=0.024). An example is shown in Figure 2.
A 6 Fr guide catheter was used in all subjects, while radial access was 
chosen in one third of cases. Multivessel procedures were performed in 
almost one third of the patients, and there were 17% of chronic total 
occlusions. Of all 126 stents implanted, 123 (98%) were third-generation 
drug-eluting stents (DES). In this registry, we noted a single stent that 
was damaged upon advancement across the metallic collar of the GL; 
damage to the (secondary) guidewire tip when passing the metallic collar 
of the GL occurred slightly more often (4/70; 6%).
DEVICE SUCCESS AND DEVICE FAILURE
The overall success rate of the GL was 93%. The average depth to 
which the GL was intubated in the proximal target vessels was 
33±22 mm (range: 0 to 106 mm), however, these generally deep intu-
bations did not cause any coronary dissections. The rate of procedural 
success of the transradial and transfemoral access routes was 95.5% 
and 88.4% (p=0.35), respectively, but the power of the study was insuf-
ficient to draw sound conclusions from this comparison. There were 
five device failures (5/70; 7%), which are illustrated in Figure 3.
COMPLICATIONS
We noted no major complications or coronary dissections. There 
were two minor complications, which are outlined below. In the 
first case, during PCI of a diffusely diseased RCA in a 53-year-old 
male, the GL was deeply advanced (61 mm intubation depth) to 
increase back-up support and to pass a balloon catheter across the 
heavily calcified distal RCA stenosis. During this manoeuvre, some 
air embolism was noted as a result of insufficient venting of the 
wedged GL, which caused a brief phase of stasis of coronary flow 
that was rapidly resolved. The second minor complication occurred 
during PCI of a long mid lesion in an RCA with “shepherd’s crook” 
anatomy. After predilatation and stenting of the mid RCA, an 
attempt to advance a second stent through the first one was made, 
which turned out to be extremely difficult. To increase support, the 
GL was advanced over both guidewires and the second stent balloon 
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system (stent still undeployed), which led to dislodgement of the 
stent from the balloon. Eventually the dislodged stent was crushed 
behind a third stent and was postdilated with high balloon pres-
sures, leading to a good final angiographic result with an uneventful 
clinical course until the eight-month follow-up.
Discussion
Good back-up of the guide catheter is crucial for both wiring and 
equipment delivery. The development of guide catheter extension 
systems has further expanded the therapeutic arsenal of the inter-
ventional cardiologist5-12. Intubation of the guide catheter extension 
system into the target vessel provides enhancement of equipment 
delivery in challenging coronary lesions, and facilitates engage-
ment in case of difficult takeoff of the coronary ostium. Takahashi 
et al demonstrated that a guide catheter extension system provides 
a substantial improvement in back-up support5. The support was 
directly related to the depth of intubation. For example, insertion of 
a 5 Fr guide catheter 15 mm into a 6 Fr catheter doubled the back-
up support. The guide catheter extension system may be used as 
a tool for deeper intubation of the guide, referred to as “rail-road-
ing”, as was described in detail by Farooq et al18. Its use in graft 
interventions is well recognised as aiding graft cannulation and 
enhancing the stability of the guide in the graft ostium. Further 
back-up may be achieved by advancing the extension catheter, 
thereby allowing the guide to back out and down until it rests on the 
aortic valve or contralateral aortic wall (Swan-neck manoeuvre)18. 
And finally, guide catheter extension systems can be used as an 
aspiration device18.
The Twente GuideLiner registry reports on a consecutive series of 
GL applications in 65 patients, treating 70 target vessels with implan-
tation of 126 stents (98% being third-generation DES). So far, this is 
the largest registry on the use of the GL in routine daily practice. 
Demographics and clinical characteristics of the study population are 
similar to previous all-comers stent studies and our general PCI pop-
ulation19-25. However, lesion characteristics differed a lot from the 
general patient population as the majority of target lesions were long 
and complex: all but two target lesions (97%) were classified as 
lesion type B2 or C with more than half of them being located dis-
tally, and the vast majority being at least moderately calcified.
During the first months, the GL was used as a bailout device in 
challenging cases, when the “old familiar tricks” (e.g., deep-seat-
ing manoeuvres or use of buddy wires) had failed. However, after 
becoming more familiar with the device, we switched to a more 
upfront use in difficult anatomical situations. In our present series, 
the main indication for GL use was to improve guide support to 
facilitate stent delivery (59%). An illustration is shown in 
Figure 2. However, in one third of the cases the GL was used to 
improve coaxial alignment of the guide catheter in anatomical sit-
uations with an abnormal takeoff of the target vessel (e.g., shep-
herd’s crook-shaped proximal RCA) or a vertical takeoff of either 
RCA or left main stem. In particular, a vertical offspring of the left 
main stem, as may be seen in young lean patients or patients with 
pulmonary emphysema, bears an increased risk of dissecting the 
left main stem with a guide catheter. Gentle intubation of the GL 
substantially facilitated the intervention in such patients 
(Figure 4). In a small number of patients, the GL was used to per-
form selective contrast injections for a better visualisation of the 
vessel of interest with smaller amounts of contrast; this indication 
for GL use may be considered in patients with large calibre ves-
sels, such as a dominant left coronary artery, and an impaired 
renal function, or if an adequate visualisation cannot be achieved 
by other means26.
The GL may also be useful to facilitate demanding diagnostic cor-
onary angiographies, which has not been described so far and was 
beyond the scope of our registry of GL use in PCI patients. 
Nevertheless, we would not like to withhold the information that our 
group also used the GL in several demanding cases of diagnostic 
angiographic visualisation of bypass grafts. Figure 5 shows an example 
of a gastroepiploic artery (GEA) graft, visualised both with and 
without use of a GL. It should be emphasised that in case of coronary 
angiography, the operator should refrain from the use of intracoro-
nary wires and devices as much as possible. However, there are 
Figure 4. Angiographic overview of a subject with a vertical offspring of the left main (A and B). The GuideLiner catheter was used for 
coaxial alignment of the guiding catheter, providing gentle intubation in the LM and good support to treat the LAD lesion.
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circumstances in which a graft cannot be properly visualised. Instead 
of accepting a poor visualisation, the use of a guide catheter exten-
sion system can be considered in order to achieve conclusive angio-
graphic imaging. It should be used by an interventional cardiologist 
with great care, and maximum effort should be taken to ensure that 
such manoeuvres do not give rise to a coronary dissection.
SUCCESS RATE, SHORTCOMINGS, AND POTENTIAL 
PROCEDURAL RISK
The success rate of the GL was 93% in our study, which is in agree-
ment with previously reported smaller case series10,15,17,18. Stent dam-
age at the site of the metallic collar of the GL occurred in one out of 
126 stents implanted, which was a drug-eluting stent with a nominal 
diameter of 3.5 mm. Others have reported a higher rate of stent dam-
age (6%) due to the collar of the GL catheter10. Therefore, we dis-
courage the use of stents with a nominal diameter of 4 mm or more 
through a “5-in-6” Fr GL catheter. Murphy et al recently reported an 
uncommon case of balloon damage at the site of the metallic collar16. 
In addition, secondary (buddy) guidewires can be damaged upon 
advancement when the GL is in place, as reported in our present 
study. The “5-in-6” Fr GL catheter permits the passage of virtually all 
regular balloon catheters, contemporary optical coherence tomogra-
phy (OCT) catheters, and coronary stents up to a nominal diameter of 
3.5 mm. However, it does not allow the use of larger devices such as 
thrombectomy catheters, some intravascular ultrasound (IVUS) 
probes, and simultaneous kissing balloon inflations.
Although the GL turned out to be generally beneficial with 
a relatively low rate of device failure, we identified some scenar-
ios, in which the usefulness of the GL may be questionable. 
Firstly, a difficult access due to iliac tortuosity may impede the 
advancement of the GL through the mother guide, as was seen in 
one of our patients. Secondly, the proximal part of the target ves-
sel should be suitable for intubation of the GL catheter; therefore, 
ostial/very proximal lesions or sharp angles of coronary arteries 
may lead to device failure, as was noted in the majority of our 
cases with device failure.
In general, use of the GL turned out to be safe. No major compli-
cations were noted, but there were two minor complications with 
favourable outcomes and an otherwise uneventful clinical course. 
There was one case of air embolism due to insufficient venting. In 
the second case, a stent was dislodged from the balloon by the tip of 
the GL when advancing the GL over a stent balloon system. Both 
complications could have been avoided, if more care had been 
taken and the instructions of the manufacturer had been followed. 
Luna et al15 reported a substantially higher number of cases with 
pressure dampening (57%) during engagement of the GL catheter; 
however, dissimilar to our study, they used a “6-in-7” Fr system in 
the majority of cases.
HOW TO USE THE GUIDELINER AND HOW TO AVOID 
COMPLICATIONS
Several considerations can be mentioned in order to choose or refrain 
from the use of a guide catheter extension. If more back-up of the 
guide catheter is required, the first step can be the use of buddy wires, 
extra stiff wires, or buddy balloons. However, if these measures fail, 
a GL catheter may be considered, which allows the mother guide and 
Figure 5. Visualisation of a gastroepiploic artery (GEA) graft in a 66-year-old male patient. Panel A shows vague images of the GEA graft, 
obtained during routine angiography two years earlier. Panel B illustrates the difference in image quality, obtained recently with the use of the 
GuideLiner (GL) catheter. The arrow in Panel C is pointed at the tip of the GL catheter.
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wires to be left in place. The operator should, however, be convinced 
that the proximal part of the target vessel is suitable for intubation. If 
the lesion extends to the proximal segment or if there is sharp angula-
tion, the use of a guide catheter extension system is generally not 
recommended. Alternatively, the proximal segment may be stented 
first, followed by gentle intubation of the GL catheter and treatment 
of the distal segment (so-called proximal-to-distal stenting). How-
ever, care should be taken to avoid deformation or longitudinal com-
pression of a proximally implanted stent27,28. If there is a problem 
with coaxial alignment of the available guide catheters, the operator 
should estimate the risk of performing the procedure with a subopti-
mal position of the tip of the guide (in case of a simple proximal 
lesion one may continue). However, if substantial back-up is required, 
it appears wise to use a guide catheter extension. This decreases the 
risk of guide-induced dissections and improves the back-up of the 
mother guide. If the patient has an impaired renal function and the 
operator expects to use large amounts of contrast (e.g., in a dominant 
left coronary artery system), a guide catheter extension system may 
be considered as a valuable first choice. And finally, if the operator 
intends to treat a bifurcation lesion, it should be realised that a “5-in-
6” Fr system does not allow the simultaneous use of two balloons. 
Therefore, a choice should be made to use a larger guide catheter 
extension system (“6-in 7” Fr system or Proxis™ device), remove the 
guide catheter extension system before the kissing procedure, or 
refrain from its use and adhere to usual practice.
A WORD OF CAUTION
Intubation of the GL bears the risk of causing a dissection in a prox-
imal coronary artery and should be performed carefully. If resist-
ance is encountered when advancing the device, the GL can be 
retrieved into the mother guide and then re-advanced over a balloon 
catheter (to improve alignment) into the target vessel17. After 
advancing the GL into the vessel, the operator should check the 
coronary pressure waves and verify the presence of adequate, pre-
served antegrade coronary flow. Since use of the GL reduces the 
size of the working lumen, there is an increased risk of air embo-
lism, which can be diminished by slow advancement and with-
drawal of the equipment; time should then be taken to carefully 
vent the system. A limitation of the GL device is the metallic collar 
located at the entrance of the extension tube. In case of resistance 
while advancing the stent, the location of the stent in relation to the 
metallic collar of the GL should be checked and the stent should be 
inspected for damage. If the collar is located at a bend in the cath-
eter, the GL should be retrieved gently into a straight section of the 
mother guide in order to allow more coaxial alignment of the 
collar17. The use of more than one guidewire in combination with 
a relatively large size of the stent delivery system may sometimes 
render stent passage through the collar of the GL difficult and occa-
sionally impossible. Factors such as operator awareness, experi-
ence, number and type of guidewires, size of the stent, vascular 
anatomy, the shape of the guide catheter, and indication for GL use 
may have an effect on the incidence of this problem, which differs 
between case series17.
LIMITATIONS
The present registry of a consecutive series of PCI patients treated 
with the use of the “5-in-6” Fr GL provides some “real-life” insight 
into efficacy, limitations, and the potential risk of this device. 
Although our patient population is larger than that of all previously 
reported cases and patient series altogether10-18 the population is still 
relatively small. In addition, due to well-known limitations inherent 
to registries, this single centre registry cannot provide the scientific 
level of insight that might be obtained from a randomised study. Dur-
ing the course of this registry, use of highly deliverable third-genera-
tion DES in most patients was our standard of care29, which could 
have affected our results. We cannot exclude that in cases with 
upfront use of the GL, a standard guide catheter or other manoeuvres 
and tricks (e.g., deep intubations or buddy wires) could also have led 
to procedural success.
CONCLUSIONS
Use of the GuideLiner catheter resulted in an increased back-up 
support and guide catheter alignment for stent delivery in the pres-
ence of unfavourable tortuous coronary anatomies and in complex, 
heavily calcified, and often distally located lesions, which other-
wise may have been considered unsuitable for PCI. The procedural 
success rate of the GL was high without major complications.
FUNDING
This investigator-initiated study was performed without specific 
funding. The research department received educational and/or 
research grants in the past and has participated in clinical studies 
funded by Abbott Vascular, Biosensors, Biotronik, Boston Scien-
tific, Cordis, and Medtronic.
Conflict of interest statement
C. von Birgelen is a consultant to and has received lecture fees or 
travel expenses from Abbott, Medtronic, and Boston Scientific and 
has received a speaker’s honorarium from Merck Sharp & Dohme. 
All of the other authors have no conflict of interest to declare.
References
 1. Burzotta F, Trani C, Mazzari MA, Mongiardo R, Rebuzzi AG, 
Buffon A, Niccoli G, Biondi-Zoccai G, Romagnoli E, Ramazzotti V, 
Schiavoni G, Crea F. Use of a second buddy wire during percutane-
ous coronary interventions: A simple solution for some challenging 
situations. J Invasive Cardiol. 2005;17:171-174.
 2. Hirokami M, Saito S, Muto H. Anchoring technique to 
improve guiding catheter support in coronary angioplasty of chronic 
total occlusions. Catheter Cardiovasc Interv. 2006;67:366-371.
 3. Peels HO, van Boven AJ, den Heijer P, Tio RA, Lie KI, 
Crijns HJ. Deep Seating of six French guiding catheters for deliv-
ery of new Palmaz-Schatz stents. Catheter Cardiovasc Interv. 
1996;38:210-213.
 4. von Sohsten R, Oz R, Marone G, McCormick DJ. Deep intu-
bation of 6F guiding catheters for transradial coronary interven-
tions. J Invasive Cardiol. 1998;10:198-202.
n   
344
EuroIntervention 2
0
12
;8
:336-344
 5. Takahashi S, Saito S, Takanak S, Miyashita Y, Shiono T, 
Arai F, Domae H, Satake S, Itoh T. New method to increase a back-
up support of a 6 French guiding coronary catheter. Catheter 
Cardiovasc Interv. 2004;63:452-456.
 6. Mamas MA, Fath-Ordoubadi F, Fraser D. Successful use of 
the Heartrail II catheter as a stent delivery catheter following failure 
of conventional techniques. Catheter Cardiovasc Interv. 2008;71:358-363.
 7. Mamas MA, Eichhöfer J, Hendry C, El-Omar M, Clarke B, 
Neyses L, Fath-Ordoubadi F, Fraser D. Use of the Heartrail II cath-
eter as a distal stent delivery device; an extended case series. 
EuroIntervention. 2009;5:265-271.17.
 8. Brilakis ES, Banerjee S. Novel uses of the Proxis embolic 
protection catheter. Catheter Cardiovasc Interv. 2009;74:438-445.
 9. Banerjee S, Brilakis ES. Use of the Proxis embolic protection 
device for guide anchoring and stent delivery during complex 
saphenous vein graft interventions. Cardiovasc Revasc Med. 
2009;10:183-187.
 10. Mamas MA, Fath-Ordoubadi F, Fraser DG. Distal stent 
delivery with GuideLiner catheter: first in man experience. Catheter 
Cardiovasc Interv. 2010;76:102-111.
 11. Kumar S, Gorog DA, Secco GG, Di Mario C, Kukreja N. 
The GuideLiner “child”catheter for percutaneous coronary interven-
tion - early clinical experience. J Invasive Cardiol. 2010;22:495-498.
 12. Rao U, Gorog D, Syzgula J, Kumar S, Stone C, Kukreja N. 
The GuideLiner “child” catheter. EuroIntervention. 2010;6:277-279.
 13. Hanna EB, Dasari TW, Hennebry TA. Use of the GuideLiner 
catheter for the treatment of a bifurcational total occlusion of the 
native left anterior descending artery through a tortuous composite 
venous graft. J Invasive Cardiol. 2011;23:E40-2.
 14. Wiper A, Mamas M, El-Omar M. Use of the GuideLiner 
catheter in facilitating coronary and graft intervention. Cardiovasc 
Revasc Med. 2011;12:68.e5-7.
 15. Luna M, Papayannis A, Holper EM, Banerjee S, Brilakis ES. 
Transfemoral use of the guideLiner catheter in complex coronary 
and bypass graft interventions. Catheter Cardiovasc Interv. 2011 
July 29. [Epub ahead of print].
 16. Murphy JC, Spence MS. Guideliner® catheter-Friend or foe? 
Catheter Cardiovasc Interv. 2011 July 29. [Epub ahead of print].
 17. Cola C, Miranda F, Vaquerizo B, Fantuzzi A, Bruguera J. The 
Guideliner™ catheter for stent delivery in difficult cases: tips and 
tricks. J Interv Cardiol. 2011;24:450-61.
 18. Farooq V, Mamas MA, Fath-Ordoubadi F, Fraser DG. The 
use of a guide catheter extension system as an aid during transradial 
percutaneous coronary intervention of coronary artery bypass 
grafts. Catheter Cardiovasc Interv. 2011;78:847-63.
 19. Tandjung K, Basalus MW, Muurman E, Louwerenburg HW, 
van Houwelingen KG, Stoel MG, de Man FH, Jansen H, Huisman J, 
Linssen GC, Droste HT, Nienhuis MB, von Birgelen C. Incidence 
of periprocedural myocardial infarction following stent deployment: 
Comparison between first- and second-generation drug-eluting stents. 
Catheter Cardiovasc Interv. 2011 Nov 22. [Epub ahead of print]
 20. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, 
Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, 
Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL; SPIRIT 
III Investigators. Randomized comparison of everolimus-eluting 
and paclitaxel-eluting stents: two-year clinical follow-up from the 
Clinical Evaluation of the Xience V Everolimus Eluting Coronary 
Stent System in the Treatment of Patients with de novo Native Coronary 
Artery Lesions (SPIRIT) III trial. Circulation. 2009;119:680-686.
 21. Windecker S, Remondino A, Eberli FR, Jüni P, Räber L, 
Wenaweser P, Togni M, Billinger M, Tüller D, Seiler C, Roffi M, 
Corti R, Sütsch G, Maier W, Lüscher T, Hess OM, Egger M, 
Meier B. Sirolimus-eluting and paclitaxel-eluting stents for coro-
nary revascularization. N Engl J Med. 2005;353:653-62.
 22. Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, 
Buszman PE, Kelbæk H, van Boven AJ, Hofma SH, Linke A, 
Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, 
Kornowski R, Ischinger T, Bartorelli A, Ronden J, Bressers M, 
Gobbens P, Negoita M, van Leeuwen F, Windecker S. Comparison 
of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents. 
N Engl J Med. 2010;363:136-146.
 23. Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, 
Goedhart D, Smits PC. Second-generation everolimus-eluting and 
paclitaxel-eluting stents in real-life practice (COMPARE): a ran-
domised trial. Lancet. 2010;375:201-209.
 24. von Birgelen C, Basalus MW, Tandjung K, van Houwelingen KG, 
Stoel MG, Louwerenburg JH, Linssen GC, Saïd SA, Kleijne MA, 
Sen H, Löwik MM, van der Palen J, Verhorst PM, de Man FH. 
A randomized controlled trial in second-generation zotarolimus-
eluting Resolute stents versus everolimus-eluting Xience V stents 
in real-world patients: The TWENTE trial. J Am Coll Cardiol. 
2012;59:1350-61.
 25. Sen H, Tandjung K, Basalus MW, Löwik MM, van 
Houwelingen GK, Stoel MG, Louwerenburg HW, de Man FH, 
Linssen GC, Nijhuis R, Nienhuis MB, Verhorst PM, van der Palen J, 
von Birgelen C. Comparison of eligible non-enrolled patients and 
the randomised TWENTE trial population treated with Resolute 
and Xience V drug-eluting stents. EuroIntervention. 2012 May 15. 
[Epub ahead of print].
 26. Tunuguntla A, Daneault B, Kirtane AJ. Novel use of the 
guideLiner catheter to minimize contrast use during PCI in a patient 
with chronic kidney disease. Catheter Cardiovasc Interv. 2011 Nov 
22. [Epub ahead of print].
 27. Hanratty CG, Walsh SJ. Longitudinal compression: a “new” 
complication with modern coronary stent platforms-time to think 
beyond deliverability? EuroIntervention. 2011;7:872-7.
 28. Williams PD, Mamas MA, Morgan KP, El-Omar M, 
Clarke B, Bainbridge A, Fath-Ordoubadi F, Fraser DG. Longitudinal 
stent deformation: a retrospective analysis of frequency and mecha-
nisms. EuroIntervention. 2011 Nov 4. [Epub ahead of print].
 29. Tandjung K, Basalus MW, Sen H, Jessurun GA, Danse PW, 
Stoel M, Linssen GC, Derks A, van Loenhout TT, Nienhuis MB, 
Hautvast RW, von Birgelen C. DUrable polymer-based sTent 
CHallenge of Promus ElemEnt versus ReSolute Integrity (DUTCH 
PEERS): rationale and study design of a randomized multicenter trial 
in a Dutch all-comers population. Am Heart J. 2012;163:557-62.
